We are live on
!
Find out more
Lord, Abbett & Co Portfolio holdings
AUM
$30.6B
1-Year Est. Return
57.44%
This Fund
S&P 500
This Quarter
Est. Return
+6.45%
1 Year Est. Return
+57.44%
3 Year Est. Return
+215.76%
5 Year Est. Return
+368.6%
10 Year Est. Return
+2,376.62%
AUM
$30.8B
AUM Growth
+$741M
(+2.5%)
Cap. Flow
-$14.8B
Cap. Flow
% of AUM
-47.97%
Top 10 Holdings %
Top 10 Hldgs %
8.31%
Holding
851
New
152
Increased
227
Reduced
305
Closed
99
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Dow Inc
DOW
|
+$92.3M |
| 2 |
Clorox
CLX
|
+$90.2M |
| 3 |
Universal Health Services
UHS
|
+$86.5M |
| 4 |
American International
AIG
|
+$81.4M |
| 5 |
Corteva
CTVA
|
+$74.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
DHR.PRA
Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A
DHR.PRA
|
+$13.2B |
| 2 |
Bank of America
BAC
|
+$164M |
| 3 |
DuPont de Nemours
DD
|
+$120M |
| 4 |
Intuitive Surgical
ISRG
|
+$102M |
| 5 |
Johnson & Johnson
JNJ
|
+$93M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 15.92% |
| 2 | Healthcare | 14.54% |
| 3 | Financials | 14.22% |
| 4 | Industrials | 11.55% |
| 5 | Consumer Discretionary | 10.69% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
MDSO
526
DELISTED
Medidata Solutions, Inc.
MDSO
| $9.49M | 0.03% |
104,870
-180,566
| -63% | -$15.8M |
|
|
MYOK
527
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $9.44M | 0.03% |
188,239
-11,383
| -6% | -$554K |
|
528
Arcos Dorados Holdings
ARCO
$1.75B
| $9.18M | 0.03% |
+1,295,410
| New | +$8.54M |
|
529
Xencor
XNCR
$1.47B
| $8.93M | 0.03% |
218,074
+28,291
| +15% | +$929K |
|
|
SKX
530
DELISTED
Skechers
SKX
| $8.89M | 0.03% |
+282,353
| New | +$8.71M |
|
531
Oceaneering
OII
$5.19B
| $8.87M | 0.03% |
+434,800
| New | +$7.7M |
|
532
Agios Pharmaceuticals
AGIO
$2.2B
| $8.82M | 0.03% |
176,761
-592
| -0.3% | -$31.6K |
|
533
Agilent Technologies
A
$38.9B
| $8.81M | 0.03% |
117,979
+12,995
| +12% | +$963K |
|
|
WPX
534
DELISTED
WPX Energy, Inc.
WPX
| $8.76M | 0.03% |
+760,994
| New | +$9.46M |
|
|
DTV
535
DELISTED
DTE Energy Company 2016 Corporate Units
DTV
| $8.65M | 0.03% |
153,870
-4,985
| -3% | -$278K |
|
536
Kaiser Aluminum
KALU
$2.65B
| $8.62M | 0.03% |
+88,300
| New | +$8.61M |
|
537
National Presto Industries
NPK
$896M
| $8.6M | 0.03% |
+92,200
| New | +$9.39M |
|
538
TriMas Corp
TRS
$1.45B
| $8.6M | 0.03% |
277,614
+36,369
| +15% | +$1.11M |
|
|
AXNX
539
DELISTED
Axonics, Inc. Common Stock
AXNX
| $8.59M | 0.03% |
+209,605
| New | +$5.89M |
|
540
Neuronetics
STIM
$126M
| $8.54M | 0.03% |
682,984
+264,568
| +63% | +$3.74M |
|
541
AdvanSix
ASIX
$546M
| $8.49M | 0.03% |
+347,650
| New | +$9.75M |
|
542
Cracker Barrel
CBRL
$1.17B
| $8.47M | 0.03% |
+49,600
| New | +$8.12M |
|
543
Personalis
PSNL
$1.28B
| $8.42M | 0.03% |
+310,000
| New | +$8.77M |
|
544
Renasant Corp
RNST
$4B
| $8.34M | 0.03% |
231,955
-116,959
| -34% | -$4.12M |
|
545
STAG Industrial
STAG
$7.77B
| $8.27M | 0.03% |
+273,600
| New | +$8.13M |
|
546
Cintas
CTAS
$84.4B
| $8.25M | 0.03% |
139,024
-20,296
| -13% | -$1.12M |
|
547
Avista
AVA
$3.43B
| $8.24M | 0.03% |
+184,826
| New | +$7.87M |
|
548
ICICI Bank
IBN
$107B
| $8.22M | 0.03% |
653,189
-236,939
| -27% | -$2.75M |
|
549
Main Street Capital
MAIN
$5B
| $8.22M | 0.03% |
+199,900
| New | +$7.96M |
|
550
Expeditors International
EXPD
$22.4B
| $8.21M | 0.03% |
108,199
-6,792
| -6% | -$513K |
|
Similar funds
Lord, Abbett & Co's Q2 2019 Portfolio in Review
As of Q2 2019, Lord, Abbett & Co held 851 positions worth $30.8B, up 2.5% from $30B the previous quarter. Its ten largest holdings account for 8.3% of the portfolio.
Lord, Abbett & Co withdrew a net $14.8B in Q2 2019, closing 99 positions and reducing 305 holdings. Its most notable exit was DuPont de Nemours, an estimated $120M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Healthcare and Financials.
Against the trend, Lord, Abbett & Co opened a new position in Dow Inc worth $86.2M.
- Lord, Abbett & Co's largest Q2 2019 buy was Dow Inc: 1,747,600 shares worth $86.2M.
- Lord, Abbett & Co added most to Clorox in Q2 2019, an estimated $90.2M increase.
- Lord, Abbett & Co's biggest Q2 2019 reduction was Danaher Corporation 4.75% Mandatory Convertible Preferred Stock, Series A, cutting an estimated $13.2B.
- Lord, Abbett & Co fully exited DuPont de Nemours in Q2 2019, selling an estimated $120M.
- Lord, Abbett & Co's ten largest holdings make up 8.3% of its $30.8B portfolio in Q2 2019.
- Lord, Abbett & Co opened 152 new positions and closed 99 in Q2 2019.
- Lord, Abbett & Co's portfolio value rose 2.5% quarter-over-quarter to $30.8B.
Based on Lord, Abbett & Co's 13F filing for Q2 2019, filed 14 Aug 2019.